BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 17884735)

  • 1. Practical methodology of meta-analysis of individual patient data using a survival outcome.
    Katsahian S; Latouche A; Mary JY; Chevret S; Porcher R
    Contemp Clin Trials; 2008 Mar; 29(2):220-30. PubMed ID: 17884735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating trial and treatment heterogeneity in an individual patient data meta-analysis of survival data by means of the penalized maximum likelihood approach.
    Rondeau V; Michiels S; Liquet B; Pignon JP
    Stat Med; 2008 May; 27(11):1894-910. PubMed ID: 18069745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Random effects survival models gave a better understanding of heterogeneity in individual patient data meta-analyses.
    Michiels S; Baujat B; Mahé C; Sargent DJ; Pignon JP
    J Clin Epidemiol; 2005 Mar; 58(3):238-45. PubMed ID: 15718112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of continuous outcome data from individual patients.
    Higgins JP; Whitehead A; Turner RM; Omar RZ; Thompson SG
    Stat Med; 2001 Aug; 20(15):2219-41. PubMed ID: 11468761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A non-parametric procedure for evaluating treatment effect in the meta-analysis of survival data.
    Moodie PF; Nelson NA; Koch GG
    Stat Med; 2004 Apr; 23(7):1075-93. PubMed ID: 15057879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating patient exclusion bias in meta-analysis.
    Tierney JF; Stewart LA
    Int J Epidemiol; 2005 Feb; 34(1):79-87. PubMed ID: 15561753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis of individual patient data versus aggregate data from longitudinal clinical trials.
    Jones AP; Riley RD; Williamson PR; Whitehead A
    Clin Trials; 2009 Feb; 6(1):16-27. PubMed ID: 19254930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis of pairs of survival curves under heterogeneity: a Poisson correlated gamma-frailty approach.
    Fiocco M; Putter H; van Houwelingen JC
    Stat Med; 2009 Dec; 28(30):3782-97. PubMed ID: 19899066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Statistical analysis of community-based studies -- presentation and comparison of possible solutions with reference to statistical meta-analytic methods].
    Twardella D; Bruckner T; Blettner M
    Gesundheitswesen; 2005 Jan; 67(1):48-55. PubMed ID: 15672306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigating heterogeneity in an individual patient data meta-analysis of time to event outcomes.
    Smith CT; Williamson PR; Marson AG
    Stat Med; 2005 May; 24(9):1307-19. PubMed ID: 15685717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of ordinal outcomes using individual patient data.
    Whitehead A; Omar RZ; Higgins JP; Savaluny E; Turner RM; Thompson SG
    Stat Med; 2001 Aug; 20(15):2243-60. PubMed ID: 11468762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An overview of methods and empirical comparison of aggregate data and individual patient data results for investigating heterogeneity in meta-analysis of time-to-event outcomes.
    Smith CT; Williamson PR; Marson AG
    J Eval Clin Pract; 2005 Oct; 11(5):468-78. PubMed ID: 16164588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of summary survival curve data.
    Arends LR; Hunink MG; Stijnen T
    Stat Med; 2008 Sep; 27(22):4381-96. PubMed ID: 18465839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-regression detected associations between heterogeneous treatment effects and study-level, but not patient-level, factors.
    Schmid CH; Stark PC; Berlin JA; Landais P; Lau J
    J Clin Epidemiol; 2004 Jul; 57(7):683-97. PubMed ID: 15358396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simple meta-analytic approach for using a binary surrogate endpoint to predict the effect of intervention on true endpoint.
    Baker SG
    Biostatistics; 2006 Jan; 7(1):58-70. PubMed ID: 15972889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proportional hazards models with frailties and random effects.
    O'Quigley J; Stare J
    Stat Med; 2002 Nov; 21(21):3219-33. PubMed ID: 12375300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iterative generalized least squares for meta-analysis of survival data at multiple times.
    Dear KB
    Biometrics; 1994 Dec; 50(4):989-1002. PubMed ID: 7787011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of continuous outcomes combining individual patient data and aggregate data.
    Riley RD; Lambert PC; Staessen JA; Wang J; Gueyffier F; Thijs L; Boutitie F
    Stat Med; 2008 May; 27(11):1870-93. PubMed ID: 18069721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adaptive risk group refinement.
    LeBlanc M; Moon J; Crowley J
    Biometrics; 2005 Jun; 61(2):370-8. PubMed ID: 16011683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of one-step and two-step meta-analysis models using individual patient data.
    Mathew T; Nordström K
    Biom J; 2010 Apr; 52(2):271-87. PubMed ID: 20349448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.